Why Hospital-Acquired Infection Surveillance Needs an Intelligence Layer

The Current State of HAI Surveillance

Hospital-acquired infections (HAIs) remain one of the most significant patient safety challenges in healthcare. CLABSI, CAUTI, SSI, MRSA, and C. diff together affect hundreds of thousands of patients annually and cost the healthcare system billions.

Despite decades of prevention efforts, most HAI surveillance still relies on infection preventionists manually reviewing lab results, clinical notes, and device data to identify and classify infections according to CDC/NHSN criteria.

Why Manual Surveillance Falls Short

Manual surveillance creates several problems:

• Delayed detection: Infections are often identified days after onset, limiting intervention options
• Incomplete capture: IP teams cannot review every patient record in large health systems
• Inconsistent classification: NHSN criteria are complex, leading to inter-rater variability
• Limited root cause analysis: Identifying correlated factors (staffing, compliance, device days) requires cross-referencing multiple data systems

What an Intelligence Layer Enables

An intelligence layer that understands clinical data natively can transform HAI surveillance:

• Real-time identification: Agents continuously monitor lab, microbiology, and device data to flag potential HAIs as they emerge
• Consistent classification: Neurosymbolic reasoning applies NHSN criteria uniformly across every case
• Correlated insights: Knowledge graphs connect infection events to staffing patterns, hand hygiene compliance, line maintenance protocols, and other contributing factors
• Shared visibility: Infection prevention teams, unit managers, and quality leadership all see the same data and the same analysis

The Path Forward

The CMS HAC Reduction Program penalizes hospitals in the bottom quartile of HAI performance. For many health systems, improving HAI surveillance is not just a clinical imperative — it is a financial one.

Moving from manual chart review to agent-driven, real-time surveillance is no longer aspirational. The technology exists today. The question is whether health systems will adopt it before the next reporting cycle.